The Possibilities of Reducing the Minimal Inhibitory Concentration of Puromycin and Ceftiofur in Their Combination with His6-OPH-Based Biologics
Crossref DOI link: https://doi.org/10.3103/S0027131418060068
Published Online: 2019-02-12
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maslova, O. V.
Aslanli, A. G.
Senko, O. V.
Efremenko, E. N.
Text and Data Mining valid from 2018-11-01
Article History
Received: 1 March 2018
First Online: 12 February 2019